期刊文献+

心血管外科术后非计划性二次开胸探查术后患者住院死亡的预后因素分析 被引量:1

The prognosis factors of hospital mortality for unplanned re-explorations after cardiovascular surgery
原文传递
导出
摘要 目的 探讨心血管外科术后行非计划性二次开胸探查术后患者住院死亡的预后因素。方法 回顾性分析2015年3月至2019年3月于首都医科大学附属北京安贞医院行心血管手术,术后滞留于ICU并行非计划性二次开胸探查手术的311例患者的资料。男性241例,女性70例,年龄(58.3±12.5)岁(范围:20~85岁)。采用Logistics回归进行多因素分析确定患者住院死亡的预后因素。构建患者住院死亡的评估模型,计算该模型的受试者工作特征曲线下面积,采用拟合优度检验进一步评价该模型的评估效能。结果 311例患者中,81例患者死亡。Logistics回归分析结果显示,二次开胸探查手术时间、探查前48 h内最差血肌酐值、探查后24 h内最差乳酸值,以及二次开胸前后发生心功能不全、呼吸功能不全、急性肾损伤是心血管外科术后二次开胸患者住院死亡的独立预后因素(P值均<0.05)。由这些预后因素构成的评估模型的曲线下面积为0.910,评估效能良好(χ2=4.243,P=0.835)。结论 二次开胸探查手术时间、探查前48 h内最差血肌酐值、探查后24 h内最差乳酸值,二次开胸前后发生心功能不全、呼吸功能不全、急性肾损伤是心血管外科术后二次开胸患者住院死亡的预后因素。明确二次开胸患者住院死亡的预后因素,能够有效指导临床医师对术后危重患者进行筛查,及时调整临床治疗策略,改善患者预后。 Objective To examine the prognosis factors of hospital mortality for unplanned re-explorations after cardiovascular surgery.Methods Totally 311 consecutive patients undergoing unplanned re-explorations after cardiovascular surgery in the Center for Cardiac Intersive Care of Beijing Anzhen Hospital,Capital Medical University between March 2015 and March 2019 were analyzed retrospectively.There were 241 males and 70 females,aging(58.3±12.5)years(range:20 to 85 years).Demographic characteristics,operation information,perioperative complications were collected to set up a database.The patients were divided into survival group and non-survival group according to in-hospital mortality.Logistic regression was used for multivariable analysis to explore the prognosis factors of hospital mortality.These statistically significant indicators were selected for plotting the receiver operation characteristic curves,calculating the area under the curve(AUC).The Hosmer-Lemeshow C-statistic was used to evaluate the efficiency of the new model.Results Hospital mortality was 26.0%(81/311).Multivariate analysis revealed that the worst serum creatinine within 48 hours before re-operation,the worst lactate during the first 24 hours after re-operation,re-operation time,cardiac dysfunction,acute kidney injury,and respiratory dysfunction were independent prognosis factors(all P<0.05).The AUC of the new assessment model constituted by these prognosis factors was 0.910,and the Hosmer-Lemeshow C-statistic was 4.243(P=0.835).Conclusions The worst serum creatinine within 48 hours before re-operation,the worst lactate during the first 24 hours after re-operation,re-operation time,cardiac dysfunction,acute kidney injury,and respiratory dysfunction were the independent prognosis factors of hospital mortality for unplanned re-explorations after cardiovascular surgery.To identify these factors can promote preventive measures effectively and improve the prognosis of patients.
作者 刘晓雨 刘楠 Liu Xiaoyu;Liu Nan(Center for Cardiac Intersive Care,Department of Cardiac Surgery,Beijing Anzhen Hospital,Capital Medical University,Beijing 100029,China)
出处 《中华外科杂志》 CAS CSCD 北大核心 2020年第4期310-314,共5页 Chinese Journal of Surgery
关键词 心血管外科手术 再手术 死亡 因素分析 统计学 Cardiovascular surgical procedures Reoperation Death Factor analysis statistical
  • 相关文献

参考文献5

二级参考文献25

  • 1朱晓东.我国心脏外科发展趋向的思考[J].中华外科杂志,2006,44(2):73-75. 被引量:3
  • 2李敬远,王俊科,曾因明.心肌缺血再灌注损伤的线粒体通透性转换机制[J].国际麻醉学与复苏杂志,2006,27(1):54-57. 被引量:7
  • 3RL Mehta,JA Kellum,S Shah,B Molitoris,C Ronco,D Warnock,A Levin,王欣.急性肾损伤诊断与分类专家共识[J].中华肾脏病杂志,2006,22(11):661-663. 被引量:356
  • 4郑明秀,左红梅,郭松青.长时间体外循环转流中乳酸的管理[J].山西医药杂志,2007,36(1):80-81. 被引量:1
  • 5Cannon CP, Mehta SR, Aranki SF. Balancing the benefit and risk of oral antiplatelet agents in coronary artery bypass surgery[J ]. Ann Thorac Surg, 2005,80 (2) : 768 - 779. 被引量:1
  • 6Ferraris VA, Ferraris SP, Molitemo DJ, et al. The Society of Thoracic Surgeons Practice Guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary)[J ]. Ann Thorac Surg, 2005,79(4) : 1454 - 1461. 被引量:1
  • 7Boldt J, Knothe C, Zickmann B, et al. The effects of preoperative aspirin therapy on platelet function in cardiac surgery[J ]. Eur J Cardiothorac Surg, 1992,6 ( 11 ) : 598 - 602. 被引量:1
  • 8Kallis P, Tooze JA,Talbot S, et al. Pre-operative aspirin decreases platelet aggregation and increases post-operative blood loss: a prospective, randomised, placebo controlled, double-blind clinical trial in 100 patients with chronic stable angina[J]. Eur J Cardiothorae Surg, 1994,8(8) :404 - 409. 被引量:1
  • 9Johnson WC, Williford WO. Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomized study [J]. J Vasc Surg, 2002, 35 (3) : 413 - 421. 被引量:1
  • 10Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients[J ]. BMJ,2002,324(7329) : 71 - 86. 被引量:1

共引文献26

同被引文献13

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部